GoodRx Holdings, Inc. (GDRX) key performance indicators and operating metrics (10 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Monthly Active Consumers | 5.3M | FY2026-Q1 |
| Adjusted Earnings Before Interest Taxes Depreciation and Amortization Margin | 30.00 percent | FY2026-Q1 |
| Adjusted Net Income Margin | 11.90 percent | FY2026-Q1 |
| Prescription Transactions Revenue | 113.7M | FY2026-Q1 |
| Subscriptions Revenue | 24.39M | FY2026-Q1 |
| Adjusted Earnings Before Interest Taxes Depreciation and Amortization | 58.3M | FY2026-Q1 |
| Adjusted Net Income | 23M | FY2026-Q1 |
| Total Subscription Plans | 717K | FY2026-Q1 |
| PharmaDirect Revenue | 52.2M | FY2026-Q1 |
| Pharma Manufacturing Solutions Revenue | 43.4M | FY2025-Q3 |
Back to GDRX overview · GDRX earnings · GDRX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.